KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES

KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES

Summary Aim: to assess the efficacy and tolerability of Consupren (Galena, Chekia ) in some rheumatic diseases. Material and methods. Three months’ therapy by Consupren was studied in 12 patients: 4 with SLE, 4 with Behcet’s disease, 2 with rheumatoid arthritis with systemic manifestations, 2 with j...

Full description

Bibliographic Details
Main Authors:	Z S Alekberova, N. S.V. Shekshina, A. V. Elonakov, V A Nassonova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2001-04-01
Series:	Научно-практическая ревматология
Subjects:	systemic lunus erythematosus juvenile rheumatoid arthritis behcet's disease consunren
Online Access:	https://rsp.mediar-press.net/rsp/article/view/536

Similar Items

Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases
by: T A Lisitsyna, et al.
Published: (2018-05-01)

Histopathology of the gut in rheumatic diseases
by: F. Macaluso, et al.
Published: (2018-10-01)

Current approaches to treatment of uveitis in immune-mediated inflammatory rheumatic disease
by: T. A. Lisitsyna, et al.
Published: (2020-09-01)

Ethnic aspects of rheumatic diseases
by: Zemfira Sadullayevna Alekberova, et al.
Published: (2012-03-01)

Place of cyclosporin A in the therapy of rheumatic diseases
by: Zemfira Sadullaevna Alekberova, et al.
Published: (2011-09-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases
by: Ilan Bank
Published: (2020-02-01)

SILK ROAD DISEASE: FROM LEGENDS TO THE 21st CENTURY
by: Z. S. Alekberova
Published: (2015-03-01)

New guidelines for the management of patients with Behcet's disease/syndrome (EULAR, 2018)
by: T. A. Lisitsyna, et al.
Published: (2019-05-01)

Secondary fibromyalgia in children with immune-inflammatory rheumatic diseases
by: A. V. Santimov, et al.
Published: (2024-06-01)

The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center
by: Fahidah AlEnzi, et al.
Published: (2020-07-01)

Behcet's disease: reproductive function and pregnancy
by: Z. S. Alekberova, et al.
Published: (2018-06-01)

Metabolic Syndrome in Rheumatic Diseases: A Review Article
by: Maryam Mobini
Published: (2021-02-01)

Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
by: D. V. Bukhanova, et al.
Published: (2019-06-01)

Mental disorders in children with rheumatic diseases
by: A. V. Santimov, et al.
Published: (2024-03-01)

Lungs damage in Behçet’s disease
by: R G Goloeva, et al.
Published: (2009-08-01)

Comorbidity in children with rheumatic diseases: literature review and 10-year experience of own research
by: L.F. Bogmat, et al.
Published: (2023-06-01)

A Gut microbiota and rheumatic diseases: new insights into pathogenesis
by: Aldona Pażyra, et al.
Published: (2024-08-01)

From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases
by: Winston Gilcrease, et al.
Published: (2024-11-01)

Behçet’s disease: Intracardiac thrombosis (a description of two cases and a review of literature)
by: Z S Alekberova, et al.
Published: (2017-05-01)

COLCHICINE IN RHEUMATOLOGY: YESTERDAY AND TODAY. WILL THERE BE TOMORROW?
by: Z S Alekberova, et al.
Published: (2010-06-01)

Comprehensive Management of Rheumatic Diseases Affecting the Temporomandibular Joint
by: Lauren Covert, et al.
Published: (2021-02-01)

IMPACT OF PREGNANCY ON THE ACTIVITY OF RHEUMATOID ARTHRITIS AND ITS THERAPY ACCORDING TO PROSPECTIVE FOLLOW-UP DATA
by: E. V. Matyanova, et al.
Published: (2015-09-01)

Cerebral Vasculitis in Juvenile Rheumatoid Arthritis
by: J Gordon Millichap
Published: (1998-08-01)

Frequency and diagnostic significance of anti-cyclic citrullinated peptide antibodies (ACCP) and anti-modified citrullinated vimentin antibodies (AMCV) in children with early juvenile arthritis
by: S O Salugina, et al.
Published: (2008-12-01)

SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIZING ACTIVITY OF B LYMPHOCYTES IN INFLAMMATORY RHEUMATIC DISEASES
by: A.T. T. Mamasaidov, et al.
Published: (2014-07-01)

ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: INTERNATIONAL DATA AND EXPERIENCE OF USAGE IN THE REPUBLIC OF MORDOVIA
by: L. A. Balykova, et al.
Published: (2014-03-01)

The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
by: Mohamed Ismail Abdelkarem, et al.
Published: (2025-07-01)

JUVENILE CHRONIC ARTHRITIS WITH EYE LESION
by: S O Salugina, et al.
Published: (2002-02-01)

The modern approach to diagnosis of juvenile arthritides
by: S O Salugina, et al.
Published: (2008-08-01)

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS
by: S O Salugina, et al.
Published: (2009-06-01)

Juvenile Behсet's Disease: Clinical Observation
by: Nikolai V. Sobotiuk, et al.
Published: (2016-09-01)

Temporomandibular joint dysfunction in various rheumatic diseases
by: F.J. Aceves-Avila, et al.
Published: (2013-07-01)

ANTICARDIOLIPIN ANTIBODIES IN EYE AND NON-EYE MANIFESTATIONS OF VASCULAR DISTURBANCES IN PATIENTS WITH BEHCET’S DISEASE
by: N A Ermakova, et al.
Published: (2000-04-01)

IMPACT OF THERAPY WITH BIOLOGICAL AGENTS ON B-LYMPHOCYTE SUBPOPULATIONS IN RHEUMATIC DISEASES: NEW EVIDENCE
by: E. V. Suponitskaya, et al.
Published: (2015-03-01)

Behcet's disease: demographic and genetic aspects (a literature review)
by: Fatima Ismailovna Izmailova, et al.
Published: (2014-03-01)

Characterization of polymorphic markers of endothelial dysfunction genes in secondary nephropathies in children with rheumatic diseases
by: Guzel K. Karymova, et al.
Published: (2024-03-01)

Epidemiology of the Epstein–Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil
by: Samires Avelino de Souza França, et al.
Published: (2022-03-01)

Ventricular and atrial function assessment with transthoracic echocardiography in patients with rheumatic inflammatory disease
by: Somayyeh Norouzi, et al.
Published: (2022-11-01)

GOLIMUMAB — A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012-07-01)